Skip to main content
main-content
Erschienen in: Die Ophthalmologie 11/2020

23.10.2020 | Therapieverfahren in der Augenheilkunde | CME

Risikofaktoren für das Offenwinkelglaukom und Empfehlungen zur Glaukomfrüherkennung

verfasst von: Univ.-Prof. Dr. med. Alexander K. Schuster, Felix M. Wagner, Norbert Pfeiffer, Esther M. Hoffmann

Erschienen in: Die Ophthalmologie | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Zusammenfassung

Offenwinkelglaukome sind eine Gruppe chronisch progredienter Optikusneuropathien mit gonioskopisch offenem Kammerwinkel. Sie stellen eine der Hauptursachen für Sehbehinderung und Blindheit in den Industrieländern dar. Im Rahmen dieses Beitrags sollen Epidemiologie und Risikofaktoren für das Auftreten des Offenwinkelglaukoms diskutiert und bewertet werden sowie das Vorgehen bei der Früherkennung eines Offenwinkelglaukoms gemäß der kürzlich erschienen S2e-Leitlinie der Arbeitsgemeinschaft der Wissenschaftlichen Fachgesellschaften (AWMF) vorgestellt werden.
Literatur
1.
Zurück zum Zitat European Glaucoma Society (2014) Terminology and guidelines for glaucoma, 4. Aufl. PubliComm, Savona European Glaucoma Society (2014) Terminology and guidelines for glaucoma, 4. Aufl. PubliComm, Savona
2.
Zurück zum Zitat Crabb DP, Smith ND, Glen FC et al (2013) How does glaucoma look?: patient perception of visual field loss. Ophthalmology 120:1120–1126 Crabb DP, Smith ND, Glen FC et al (2013) How does glaucoma look?: patient perception of visual field loss. Ophthalmology 120:1120–1126
3.
Zurück zum Zitat Weih LM, Nanjan M, Mccarty CA et al (2001) Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology 108:1966–1972 Weih LM, Nanjan M, Mccarty CA et al (2001) Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology 108:1966–1972
4.
Zurück zum Zitat Garway-Heath DF, Crabb DP, Bunce C et al (2015) Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 385:1295–1304 Garway-Heath DF, Crabb DP, Bunce C et al (2015) Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 385:1295–1304
5.
Zurück zum Zitat Leske MC, Heijl A, Hussein M et al (2003) Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121:48–56 Leske MC, Heijl A, Hussein M et al (2003) Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121:48–56
6.
Zurück zum Zitat Leske MC, Heijl A, Hyman L et al (2007) Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114:1965–1972 Leske MC, Heijl A, Hyman L et al (2007) Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114:1965–1972
8.
Zurück zum Zitat Tham YC, Li X, Wong TY et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081–2090 Tham YC, Li X, Wong TY et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081–2090
9.
Zurück zum Zitat Hohn R, Nickels S, Schuster AK et al (2018) Prevalence of glaucoma in Germany: results from the Gutenberg Health Study. Graefes Arch Clin Exp Ophthalmol 256:1695–1702 Hohn R, Nickels S, Schuster AK et al (2018) Prevalence of glaucoma in Germany: results from the Gutenberg Health Study. Graefes Arch Clin Exp Ophthalmol 256:1695–1702
10.
Zurück zum Zitat Kapetanakis VV, Chan MP, Foster PJ et al (2016) Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol 100:86–93 Kapetanakis VV, Chan MP, Foster PJ et al (2016) Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol 100:86–93
11.
Zurück zum Zitat Astrom S, Stenlund H, Linden C (2007) Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up. Acta Ophthalmol Scand 85:832–837 Astrom S, Stenlund H, Linden C (2007) Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up. Acta Ophthalmol Scand 85:832–837
12.
Zurück zum Zitat Cedrone C, Mancino R, Ricci F et al (2012) The 12-year incidence of glaucoma and glaucoma-related visual field loss in Italy: the Ponza eye study. J Glaucoma 21:1–6 Cedrone C, Mancino R, Ricci F et al (2012) The 12-year incidence of glaucoma and glaucoma-related visual field loss in Italy: the Ponza eye study. J Glaucoma 21:1–6
13.
Zurück zum Zitat Czudowska MA, Ramdas WD, Wolfs RC et al (2010) Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Ophthalmology 117:1705–1712 Czudowska MA, Ramdas WD, Wolfs RC et al (2010) Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Ophthalmology 117:1705–1712
14.
Zurück zum Zitat De Voogd S, Ikram MK, Wolfs RC et al (2005) Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study. Ophthalmology 112:1487–1493 De Voogd S, Ikram MK, Wolfs RC et al (2005) Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study. Ophthalmology 112:1487–1493
15.
Zurück zum Zitat Hitzl W, Stollinger M, Grabner G et al (2006) The Salzburg-Moorfields Collaborative Glaucoma Study: first results of the prevalence and 5‑year incidences in this prospective, population-based longitudinal study. Klin Monatsbl Augenheilkd 223:970–973 Hitzl W, Stollinger M, Grabner G et al (2006) The Salzburg-Moorfields Collaborative Glaucoma Study: first results of the prevalence and 5‑year incidences in this prospective, population-based longitudinal study. Klin Monatsbl Augenheilkd 223:970–973
16.
Zurück zum Zitat Kawasaki R, Wang JJ, Rochtchina E et al (2013) Retinal vessel caliber is associated with the 10-year incidence of glaucoma: the Blue Mountains Eye Study. Ophthalmology 120:84–90 Kawasaki R, Wang JJ, Rochtchina E et al (2013) Retinal vessel caliber is associated with the 10-year incidence of glaucoma: the Blue Mountains Eye Study. Ophthalmology 120:84–90
17.
Zurück zum Zitat Mukesh BN, Mccarty CA, Rait JL et al (2002) Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology 109:1047–1051 Mukesh BN, Mccarty CA, Rait JL et al (2002) Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology 109:1047–1051
18.
Zurück zum Zitat Leske MC, Wu SY, Honkanen R et al (2007) Nine-year incidence of open-angle glaucoma in the Barbados Eye Studies. Ophthalmology 114:1058–1064 Leske MC, Wu SY, Honkanen R et al (2007) Nine-year incidence of open-angle glaucoma in the Barbados Eye Studies. Ophthalmology 114:1058–1064
19.
Zurück zum Zitat Pan CW, Yang WY, Hu DN et al (2017) Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese. Am J Ophthalmol 176:127–133 Pan CW, Yang WY, Hu DN et al (2017) Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese. Am J Ophthalmol 176:127–133
20.
Zurück zum Zitat Varma R, Wang D, Wu C et al (2012) Four-year incidence of open-angle glaucoma and ocular hypertension: the Los Angeles Latino Eye Study. Am J Ophthalmol 154:315–325.e311 Varma R, Wang D, Wu C et al (2012) Four-year incidence of open-angle glaucoma and ocular hypertension: the Los Angeles Latino Eye Study. Am J Ophthalmol 154:315–325.e311
21.
Zurück zum Zitat Vijaya L, Rashima A, Panday M et al (2014) Predictors for incidence of primary open-angle glaucoma in a South Indian population: the Chennai eye disease incidence study. Ophthalmology 121:1370–1376 Vijaya L, Rashima A, Panday M et al (2014) Predictors for incidence of primary open-angle glaucoma in a South Indian population: the Chennai eye disease incidence study. Ophthalmology 121:1370–1376
22.
Zurück zum Zitat Ramdas WD, Wolfs RC, Hofman A et al (2011) Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam Study. Invest Ophthalmol Vis Sci 52:6875–6881 Ramdas WD, Wolfs RC, Hofman A et al (2011) Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam Study. Invest Ophthalmol Vis Sci 52:6875–6881
23.
Zurück zum Zitat Le A, Mukesh BN, Mccarty CA et al (2003) Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 44:3783–3789 Le A, Mukesh BN, Mccarty CA et al (2003) Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 44:3783–3789
24.
Zurück zum Zitat Ekstrom C (2012) Risk factors for incident open-angle glaucoma: a population-based 20-year follow-up study. Acta Ophthalmol 90:316–321 Ekstrom C (2012) Risk factors for incident open-angle glaucoma: a population-based 20-year follow-up study. Acta Ophthalmol 90:316–321
25.
Zurück zum Zitat Mitchell P, Rochtchina E, Lee AJ et al (2002) Bias in self-reported family history and relationship to glaucoma: the Blue Mountains Eye Study. Ophthalmic Epidemiol 9:333–345 Mitchell P, Rochtchina E, Lee AJ et al (2002) Bias in self-reported family history and relationship to glaucoma: the Blue Mountains Eye Study. Ophthalmic Epidemiol 9:333–345
26.
Zurück zum Zitat Kass MA, Heuer DK, Higginbotham EJ et al (2002) The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713 (discussion 829–730) Kass MA, Heuer DK, Higginbotham EJ et al (2002) The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713 (discussion 829–730)
27.
Zurück zum Zitat Miglior S, Zeyen T, Pfeiffer N et al (2005) Results of the European Glaucoma Prevention Study. Ophthalmology 112:366–375 Miglior S, Zeyen T, Pfeiffer N et al (2005) Results of the European Glaucoma Prevention Study. Ophthalmology 112:366–375
28.
Zurück zum Zitat Cook JA, Botello AP, Elders A et al (2012) Systematic review of the agreement of tonometers with Goldmann applanation tonometry. Ophthalmology 119:1552–1557 Cook JA, Botello AP, Elders A et al (2012) Systematic review of the agreement of tonometers with Goldmann applanation tonometry. Ophthalmology 119:1552–1557
29.
Zurück zum Zitat Miglior S, Pfeiffer N, Torri V et al (2007) Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114:3–9 Miglior S, Pfeiffer N, Torri V et al (2007) Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114:3–9
30.
Zurück zum Zitat Reiter C, Gramer E, Gramer G (2012) Pseudoexfoliation syndrome: no central zone of pseudoexfoliation material in patients with pseudophakia—a clinical study. Klin Monatsbl Augenheilkd 229:241–245 Reiter C, Gramer E, Gramer G (2012) Pseudoexfoliation syndrome: no central zone of pseudoexfoliation material in patients with pseudophakia—a clinical study. Klin Monatsbl Augenheilkd 229:241–245
31.
Zurück zum Zitat Siddiqui Y, Ten Hulzen RD, Cameron JD et al (2003) What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol 135:794–799 Siddiqui Y, Ten Hulzen RD, Cameron JD et al (2003) What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol 135:794–799
32.
Zurück zum Zitat Marcus MW, Muskens RP, Ramdas WD et al (2012) Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study. Drugs Aging 29:963–970 Marcus MW, Muskens RP, Ramdas WD et al (2012) Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study. Drugs Aging 29:963–970
33.
Zurück zum Zitat Alfano JE (1963) Changes in the intraocular pressure associated with systemic steroid therapy. Am J Ophthalmol 56:245–247 Alfano JE (1963) Changes in the intraocular pressure associated with systemic steroid therapy. Am J Ophthalmol 56:245–247
34.
Zurück zum Zitat Armaly MF (1963) Effect of corticosteroids on Intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye. Arch Ophthalmol 70:482–491 Armaly MF (1963) Effect of corticosteroids on Intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye. Arch Ophthalmol 70:482–491
35.
Zurück zum Zitat Bernstein HN, Schwartz B (1962) Effects of long-term systemic steroids on ocular pressure and tonographic values. Arch Ophthalmol 68:742–753 Bernstein HN, Schwartz B (1962) Effects of long-term systemic steroids on ocular pressure and tonographic values. Arch Ophthalmol 68:742–753
36.
Zurück zum Zitat Ahmadi N, Snidvongs K, Kalish L et al (2015) Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials. Rhinology 53:290–302 Ahmadi N, Snidvongs K, Kalish L et al (2015) Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials. Rhinology 53:290–302
37.
Zurück zum Zitat Valenzuela CV, Liu JC, Vila PM et al (2019) Intranasal corticosteroids do not lead to ocular changes: a systematic review and meta-analysis. Laryngoscope 129:6–12 Valenzuela CV, Liu JC, Vila PM et al (2019) Intranasal corticosteroids do not lead to ocular changes: a systematic review and meta-analysis. Laryngoscope 129:6–12
38.
Zurück zum Zitat Mitchell P, Cumming RG, Mackey DA (1999) Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology 106:2301–2306 Mitchell P, Cumming RG, Mackey DA (1999) Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology 106:2301–2306
39.
Zurück zum Zitat Becker B, Mills DW (1963) Corticosteroids and intraocular pressure. Arch Ophthalmol 70:500–507 Becker B, Mills DW (1963) Corticosteroids and intraocular pressure. Arch Ophthalmol 70:500–507
40.
Zurück zum Zitat Chang DF, Tan JJ, Tripodis Y (2011) Risk factors for steroid response among cataract patients. J Cataract Refract Surg 37:675–681 Chang DF, Tan JJ, Tripodis Y (2011) Risk factors for steroid response among cataract patients. J Cataract Refract Surg 37:675–681
41.
Zurück zum Zitat Kiddee W, Trope GE, Sheng L et al (2013) Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv Ophthalmol 58:291–310 Kiddee W, Trope GE, Sheng L et al (2013) Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv Ophthalmol 58:291–310
42.
Zurück zum Zitat Augustin AJ, Bopp S, Fechner M et al (2020) Three-year results from the retro-IDEAL study: real-world data from diabetic macular edema (DME) patients treated with ILUVIEN(®) (0.19 mg fluocinolone acetonide implant). Eur J Ophthalmol 30:382–391 Augustin AJ, Bopp S, Fechner M et al (2020) Three-year results from the retro-IDEAL study: real-world data from diabetic macular edema (DME) patients treated with ILUVIEN(®) (0.19 mg fluocinolone acetonide implant). Eur J Ophthalmol 30:382–391
43.
Zurück zum Zitat Hollands H, Johnson D, Hollands S et al (2013) Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review. JAMA 309:2035–2042 Hollands H, Johnson D, Hollands S et al (2013) Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review. JAMA 309:2035–2042
44.
Zurück zum Zitat Crowston JG, Hopley CR, Healey PR et al (2004) The effect of optic disc diameter on vertical cup to disc ratio percentiles in a population based cohort: the Blue Mountains Eye Study. Br J Ophthalmol 88:766–770 Crowston JG, Hopley CR, Healey PR et al (2004) The effect of optic disc diameter on vertical cup to disc ratio percentiles in a population based cohort: the Blue Mountains Eye Study. Br J Ophthalmol 88:766–770
45.
Zurück zum Zitat Gupta P, Zhao D, Guallar E et al (2016) Prevalence of Glaucoma in the United States: The 2005–2008 National Health and Nutrition Examination Survey. Invest Ophthalmol Vis Sci 57:2905–2913 Gupta P, Zhao D, Guallar E et al (2016) Prevalence of Glaucoma in the United States: The 2005–2008 National Health and Nutrition Examination Survey. Invest Ophthalmol Vis Sci 57:2905–2913
46.
Zurück zum Zitat Kim KE, Park KH (2017) Optic disc hemorrhage in glaucoma: pathophysiology and prognostic significance. Curr Opin Ophthalmol 28:105–112 Kim KE, Park KH (2017) Optic disc hemorrhage in glaucoma: pathophysiology and prognostic significance. Curr Opin Ophthalmol 28:105–112
47.
Zurück zum Zitat Deva NC, Insull E, Gamble G et al (2008) Risk factors for first presentation of glaucoma with significant visual field loss. Clin Exp Ophthalmol 36:217–221 Deva NC, Insull E, Gamble G et al (2008) Risk factors for first presentation of glaucoma with significant visual field loss. Clin Exp Ophthalmol 36:217–221
48.
Zurück zum Zitat Li T, Lindsley K, Rouse B et al (2016) Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology 123:129–140 Li T, Lindsley K, Rouse B et al (2016) Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology 123:129–140
49.
Zurück zum Zitat Chan MPY, Broadway DC, Khawaja AP et al (2017) Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study. BMJ 358:j3889 Chan MPY, Broadway DC, Khawaja AP et al (2017) Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study. BMJ 358:j3889
50.
Zurück zum Zitat Vessani RM, Moritz R, Batis L et al (2009) Comparison of quantitative imaging devices and subjective optic nerve head assessment by general ophthalmologists to differentiate normal from glaucomatous eyes. J Glaucoma 18:253–261 Vessani RM, Moritz R, Batis L et al (2009) Comparison of quantitative imaging devices and subjective optic nerve head assessment by general ophthalmologists to differentiate normal from glaucomatous eyes. J Glaucoma 18:253–261
51.
Zurück zum Zitat Abrams LS, Scott IU, Spaeth GL et al (1994) Agreement among optometrists, ophthalmologists, and residents in evaluating the optic disc for glaucoma. Ophthalmology 101:1662–1667 Abrams LS, Scott IU, Spaeth GL et al (1994) Agreement among optometrists, ophthalmologists, and residents in evaluating the optic disc for glaucoma. Ophthalmology 101:1662–1667
52.
Zurück zum Zitat Wang F, Tielsch JM, Ford DE et al (1998) Evaluation of screening schemes for eye disease in a primary care setting. Ophthalmic Epidemiol 5:69–82 Wang F, Tielsch JM, Ford DE et al (1998) Evaluation of screening schemes for eye disease in a primary care setting. Ophthalmic Epidemiol 5:69–82
53.
Zurück zum Zitat Katz J, Sommer A (1990) Screening for glaucomatous visual field loss. The effect of patient reliability. Ophthalmology 97:1032–1037 Katz J, Sommer A (1990) Screening for glaucomatous visual field loss. The effect of patient reliability. Ophthalmology 97:1032–1037
55.
Zurück zum Zitat Liu H, Li L, Wormstone IM et al (2019) Development and validation of a deep learning system to detect glaucomatous optic neuropathy using fundus photographs. JAMA Ophthalmol 137:1353–1360 Liu H, Li L, Wormstone IM et al (2019) Development and validation of a deep learning system to detect glaucomatous optic neuropathy using fundus photographs. JAMA Ophthalmol 137:1353–1360
56.
Zurück zum Zitat Tuck MW, Crick RP (1997) The cost-effectiveness of various modes of screening for primary open angle glaucoma. Ophthalmic Epidemiol 4:3–17 Tuck MW, Crick RP (1997) The cost-effectiveness of various modes of screening for primary open angle glaucoma. Ophthalmic Epidemiol 4:3–17
58.
Zurück zum Zitat Rotchford AP, Uppal S, Lakshmanan A et al (2012) Day-to-day variability in intraocular pressure in glaucoma and ocular hypertension. Br J Ophthalmol 96:967–970 Rotchford AP, Uppal S, Lakshmanan A et al (2012) Day-to-day variability in intraocular pressure in glaucoma and ocular hypertension. Br J Ophthalmol 96:967–970
59.
Zurück zum Zitat Gramer G, Gramer E (2018) Stage of visual field loss and age at diagnosis in 1988 patients with different glaucomas: implications for glaucoma screening and driving ability. Int Ophthalmol 38:429–441 Gramer G, Gramer E (2018) Stage of visual field loss and age at diagnosis in 1988 patients with different glaucomas: implications for glaucoma screening and driving ability. Int Ophthalmol 38:429–441
Metadaten
Titel
Risikofaktoren für das Offenwinkelglaukom und Empfehlungen zur Glaukomfrüherkennung
verfasst von
Univ.-Prof. Dr. med. Alexander K. Schuster
Felix M. Wagner
Norbert Pfeiffer
Esther M. Hoffmann
Publikationsdatum
23.10.2020
Verlag
Springer Medizin
Erschienen in
Die Ophthalmologie / Ausgabe 11/2020
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-020-01251-x

Weitere Artikel der Ausgabe 11/2020

Die Ophthalmologie 11/2020 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde